Kynurenine-3-monooxygenase (KMO) Broadly Inhibits Viral Infections Via Triggering NMDAR/Ca2+ Influx and CaMKII/ IRF3-mediated IFN-β Production
Overview
Authors
Affiliations
Tryptophan (Trp) metabolism through the kynurenine pathway (KP) is well known to play a critical function in cancer, autoimmune and neurodegenerative diseases. However, its role in host-pathogen interactions has not been characterized yet. Herein, we identified that kynurenine-3-monooxygenase (KMO), a key rate-limiting enzyme in the KP, and quinolinic acid (QUIN), a key enzymatic product of KMO enzyme, exerted a novel antiviral function against a broad range of viruses. Mechanistically, QUIN induced the production of type I interferon (IFN-I) via activating the N-methyl-d-aspartate receptor (NMDAR) and Ca2+ influx to activate Calcium/calmodulin-dependent protein kinase II (CaMKII)/interferon regulatory factor 3 (IRF3). Importantly, QUIN treatment effectively inhibited viral infections and alleviated disease progression in mice. Furthermore, kmo-/- mice were vulnerable to pathogenic viral challenge with severe clinical symptoms. Collectively, our results demonstrated that KMO and its enzymatic product QUIN were potential therapeutics against emerging pathogenic viruses.
Wu F, Wang C, Li S, Ye Y, Cui M, Liu Y Viruses. 2024; 16(2).
PMID: 38400053 PMC: 10893112. DOI: 10.3390/v16020278.
Special Issue: "Innate Immunity to Virus Infection, 1st Edition".
Wang C, Ma F, Sun C Viruses. 2023; 15(10).
PMID: 37896837 PMC: 10612017. DOI: 10.3390/v15102060.
Blanco F, Bigi M, Garcia E, Elola M, Vazquez C, Bigi F Pathogens. 2023; 12(9).
PMID: 37764968 PMC: 10536033. DOI: 10.3390/pathogens12091159.
The kynurenine pathway relates to post-acute COVID-19 objective cognitive impairment and PASC.
Cysique L, Jakabek D, Bracken S, Allen-Davidian Y, Heng B, Chow S Ann Clin Transl Neurol. 2023; 10(8):1338-1352.
PMID: 37318955 PMC: 10424655. DOI: 10.1002/acn3.51825.
Glucocorticoid Hormones as Modulators of the Kynurenine Pathway in Chronic Pain Conditions.
Jovanovic F, Jovanovic V, Knezevic N Cells. 2023; 12(8).
PMID: 37190087 PMC: 10136661. DOI: 10.3390/cells12081178.